POPEYE Study - A 4 week randomised, double blind, placebo controlled, parallel group phase 2 proof of principle study to assess efficacy and safety of AZD1981 in adult patients with asthma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2012
At a glance
- Drugs AZD 1981 (Primary)
- Indications Asthma
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms POPEYE
- Sponsors AstraZeneca
- 07 Nov 2012 Planned number of patients changed from 4 to 110.
- 07 Dec 2006 New trial record.